临床试验解决方案提供商Sitero签署协议收购Axiom实时指标，扩大全球足迹并加强技术支持的临床服务-动脉网

Sitero Signs Agreement to Acquire Axiom Real-Time Metrics, Expanding Global Footprint and Strengthening Technology-Enabled Clinical Services

CISION 等信源发布 2025-07-08 02:53



可切换为仅中文







MIAMI, Fla.

迈阿密，佛罗里达州

，

July 7, 2025

2025年7月7日

/PRNewswire/ -- Sitero, a leading provider of clinical and regulatory services, today announced that it has signed a definitive agreement to acquire the assets and business of Axiom Real-Time Metrics Inc. from its proposed court-appointed receiver and manager, KSV Restructuring Inc., Axiom is recognized for its innovation in eClinical solutions and full-service global clinical operations..

/PRNewswire/ -- 临床和监管服务的领先提供商Sitero今天宣布，已与拟议中的法院指定接管人兼管理人KSV重组公司签署了一项最终协议，收购Axiom实时指标公司的资产和业务。Axiom以其在电子临床解决方案和全球临床运营全服务方面的创新而闻名。

This transaction, if completed, marks a significant milestone for Sitero and its ability to deliver flexible, efficient, and technology-enabled services to the global life sciences community. Since its founding in 2001, Axiom has supported hundreds of global clinical trials spanning Phase I to Phase IV across device, pharmaceutical, and biotech sectors..

如果完成，这笔交易将标志着Sitero的一个重要里程碑，以及其为全球生命科学界提供灵活、高效和技术支持服务的能力。自2001年成立以来，Axiom已支持了数百项覆盖设备、制药和生物技术领域的全球临床试验，范围从I期到IV期。

The proposed transaction remains subject to a number of conditions including Sitero's ability to obtain consent from certain customers. The transaction is also subject to approval of the Ontario Superior Court of Justice (Commercial List) in proposed receivership proceedings of Axiom, which hearing is scheduled for .

拟议的交易仍受多项条件的约束，包括Sitero能否获得某些客户的同意。该交易还须经安大略省高等法院（商业名单）在Axiom拟议的接管程序中批准，该听证会已安排在进行。

Friday July 11, 2025

2025年7月11日，星期五

. If the transaction is approved by the Court, Sitero plans to close the transaction by

如果法院批准了这项交易，Sitero 计划完成这项交易

July 15, 2025

2025年7月15日

in order to provide an efficient transition for customers.

为了给客户提供高效的过渡。

Sitero's acquisition of the Axiom platform will further Sitero's mission to accelerate clinical development through modern, tech-enabled solutions tailored to the evolving needs of sponsors. By integrating Axiom's proprietary eClinical Fusion platform and deep data expertise, Sitero advances its position as a next-generation clinical services partner offering comprehensive technology and clinical operations support..

Sitero收购Axiom平台将进一步推动Sitero通过现代化、技术赋能的解决方案来加速临床开发的使命，以满足申办方不断变化的需求。通过整合Axiom专有的eClinical Fusion平台及其深厚的数据专业知识，Sitero巩固了其作为下一代临床服务合作伙伴的地位，提供全面的技术和临床运营支持。

'We will be thrilled to welcome Axiom to the Sitero family,' said Sankesh Abbhi, CEO of Sitero. 'The Axiom platform is known for delivering innovative, customer-centric clinical solutions. With this acquisition, we will form a more powerful platform, ensuring continuity for clients while expanding our ability to deliver global trials with greater agility and scale.'.

“我们非常高兴欢迎Axiom加入Sitero大家庭，”Sitero首席执行官Sankesh Abbhi表示。“Axiom平台以其创新的、以客户为中心的临床解决方案而闻名。通过此次收购，我们将打造一个更强大的平台，在确保客户业务连续性的同时，进一步提升我们以更高敏捷性和规模开展全球试验的能力。”

Sitero's investment in advanced technology, data-driven infrastructure, and process innovation complements Axiom's capabilities in eClinical software and full-service clinical delivery. Clients from both organizations will benefit from an expanded global presence and enhanced service offerings.

西特罗在先进技术和数据驱动的基础设施以及流程创新方面的投资，与Axiom在电子临床软件和全方位临床服务交付方面的能力相辅相成。两家公司的客户都将受益于更广泛的全球布局和增强的服务提供。

Upon closing, the acquisition will also advance the integration of AI-driven capabilities into Sitero's proprietary Mentor eClinical suite. Leveraging Axiom's proven platform and Sitero's ongoing AI investments, the combined organization is positioned to drive significant efficiency gains, improve trial oversight, and reduce development timelines across clinical programs..

交易完成后，还将推动人工智能驱动的功能整合到Sitero专有的Mentor eClinical套件中。通过结合Axiom经过验证的平台和Sitero在人工智能领域的持续投资，合并后的机构将有能力推动显著的效率提升、改进试验监督，并缩短各临床项目开发时间。

About Sitero

关于Sitero

Sitero is a next-generation clinical research partner supporting life sciences and institutional research organizations in bringing treatments to market safer and faster. Through a technology-forward approach, Sitero streamlines research, drives compliance, and unlocks innovation. With global offices in the US, UK, .

西特罗是一家下一代临床研究合作伙伴，支持生命科学和机构研究组织更安全、更快地将治疗推向市场。通过技术领先的方法，西特罗简化了研究流程，推动合规并释放创新潜力。公司在美国、英国设有全球办事处。

Canada

加拿大

，

Poland

波兰

，

Australia

澳大利亚

，

Mexico

墨西哥